InMed Pharmaceuticals (INM) Long-Term Deferred Tax (2020 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Long-Term Deferred Tax of $5.4 million for Q2 2025, down 28.0% year-over-year from $7.5 million in Q2 2024, and down 28.0% quarter-over-quarter from $7.5 million in Q2 2024.
InMed Pharmaceuticals (INM) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends
InMed Pharmaceuticals' Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $5.4 million for Q2 2025.
- In Q2 2025, Long-Term Deferred Tax fell 28.0% year-over-year to $5.4 million; the TTM figure through Jun 2025 stood at $5.4 million (down 28.0% YoY), while the FY2025 annual figure was $5.4 million, down 28.0% from the prior year.
- Long-Term Deferred Tax for Q2 2025 stood at $5.4 million, down from $7.5 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $21.0 million in Q2 2023, with the low at $259457.0 in Q2 2021.
- The 5-year median for Long-Term Deferred Tax is $7.5 million (2024), against an average of $10.6 million.
- The sharpest annual moves came in 2022 and 2024: Long-Term Deferred Tax surged 7100.28% in 2022, then sank 64.33% in 2024.
- InMed Pharmaceuticals' Long-Term Deferred Tax stood at $259457.0 in 2021, then soared by 7100.28% to $18.7 million in 2022, then grew by 12.56% to $21.0 million in 2023, then tumbled by 64.33% to $7.5 million in 2024, then slipped by 28.0% to $5.4 million in 2025.
- Business Quant data shows INM's Long-Term Deferred Tax at $5.4 million in Q2 2025, $7.5 million in Q2 2024, and $21.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | InMed Pharmaceuticals | 6.44 Mn | 1.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5.40 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Jun 30, 2023 | 21.03 Mn |
| Jun 30, 2022 | 18.68 Mn |
| Jun 30, 2021 | 259,457.00 |
| Jun 30, 2020 | 287,874.00 |